No description
-
2016 (v1)PublicationUploaded on: April 14, 2023
-
2015 (v1)Publication
SSc is clinically and aetiopathogenically heterogeneous. Consensus standards for more uniform trial design and selection of outcome measures are needed. The objective of this study was to develop evidence-based points to consider (PTCs) for future clinical trials in SSc.
Uploaded on: April 14, 2023 -
2018 (v1)Publication
To describe differences in clinical presentation between men and women in a large group of patients with early (<3 years' duration) systemic sclerosis (SSc) according to disease subsets.
Uploaded on: April 14, 2023 -
2011 (v1)Publication
No description
Uploaded on: May 13, 2023 -
2019 (v1)Publication
Racial factors play a significant role in SSc. We evaluated differences in SSc presentations between white patients (WP), Asian patients (AP) and black patients (BP) and analysed the effects of geographical locations.
Uploaded on: April 14, 2023